A care bundle approach for prevention of ventilator-associated pneumonia

J Rello1, E Afonso, T Lisboa

  • 1Hospital Vall d'Hebron, CIBERES, VHIR, Universitat Autónoma de Barcelona, Barcelona, Spain. jrello@crips.es

Insights

Implementing a care bundle significantly reduced ventilator-associated pneumonia (VAP) rates and intensive care unit stays, even with low compliance. Key interventions included hand hygiene and sedation control for better patient outcomes.

Area of Science:

  • Critical Care Medicine
  • Infectious Disease Prevention
  • Healthcare Quality Improvement

Background:

  • Ventilator-associated pneumonia (VAP) poses a significant threat to patient outcomes in intensive care units (ICUs).
  • Long-term validation of care bundle effectiveness for VAP prevention is crucial.
  • Multi-centre studies are essential for robustly assessing interventions.

Purpose of the Study:

  • To evaluate the long-term impact of a VAP prevention care bundle on patient outcomes.
  • To identify specific components of the care bundle most associated with VAP reduction.
  • To assess compliance rates with the implemented care bundle.

Main Methods:

  • A collaborative multi-centre cohort study was conducted across five Spanish adult ICUs.
  • A 3-month baseline period was followed by a 16-month prospective recording of VAP rates, ICU length of stay (LOS), and mechanical ventilation duration after implementing a five-measure care bundle.
  • Patient data from 149 individuals during baseline and 885 during the intervention period were analyzed.

Main Results:

  • VAP incidence decreased from 15.5% to 11.7% post-intervention (p <0.05), despite overall compliance with the care bundle being below 30%.
  • Significant reductions in VAP were associated with hand hygiene (OR=0.35), intra-cuff pressure control (OR=0.21), oral hygiene (OR=0.23), and sedation control (OR=0.51).
  • Patients with full bundle compliance experienced reduced median ICU LOS (10 to 6 days) and mechanical ventilation duration (8 to 4 days).

Conclusions:

  • The VAP prevention care bundle demonstrated effectiveness in reducing VAP incidence and improving patient outcomes, including ICU LOS and ventilation duration.
  • Hand hygiene, intra-cuff pressure control, oral hygiene, and sedation control were key drivers of VAP reduction.
  • Future efforts should prioritize enhancing compliance with these specific VAP prevention measures to maximize patient benefit.

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: